20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T14175 | Aldose reductase-IN-1 | AT-001,Caficrestat | Others , Reductase |
Aldose reductase-IN-1 (AT-001) is a aldose reductase inhibitor (IC50: 28.9 pM). | |||
T16910 | Sorbinil | Reductase | |
Sorbinil is an Aldose reductase inhibitor. Sorbinil plays a therapeutic role in treating diabetes and diabetic complications decreases AR activity and inhibit the polyol pathway. | |||
T22757 | EBPC | Reductase | |
EBPC is an inhibitor of aldose reductase. | |||
T6S2384 | Poliumoside | Reductase | |
Poliumoside is a natural compound which exhibits significant inhibition of advanced glycation end product formation with IC50 value of 4.6-25.7 μM, it also exhibits great inhibitory effects on rat lens aldose reductase w... | |||
T23403 | Sulindac sulfone | Reductase , COX | |
Sulindac sulfone is a metabolite of the nonsteroidal anti-inflammatory drug sulindac. | |||
T10393 | AT-007 | Reductase | |
AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM). It reduces toxic galactitol levels and prevents disease complications in GALT deficiency rats. | |||
T2013 | Ponalrestat | Reductase | |
Ponalrestat is an aldose reductase inhibitor. | |||
T35317 | Zopolrestat | CP 73850,CP73850,CP-73850,Zopolrestatum | Reductase |
Zopolrestat (CP 73850) is a potent inhibitor of aldose reductase (IC50 = 3.1 nM). | |||
T17114 | Tolrestat | AY-27773 | Reductase |
Tolrestat (AY-27773) is a potent inhibitor of aldose reductase (IC50 = 35 nM). | |||
T62951 | Aldose reductase-IN-2 | ||
Aldose reductase-IN-2 (Compound 5f) is a potent inhibitor of aldose reductase (AR) with antioxidant properties. aldose reductase-IN-2 is a promising anti-diabetic complication drug. | |||
T5S1131 | Ganoderic acid C6 | Others | |
1. Ganoderic acid C6 has antinociceptive activity. | |||
T61555 | Aldose reductase-IN-6 | ||
Aldose reductase-IN-6 (Compound 3) is a competitive inhibitor of aldose reductase (AR), possessing an IC50 of 3.164 μM and a Ki of 0.018 μM. Notably, Aldose reductase-IN-6 demonstrates no cytotoxicity toward normal cells... | |||
T60897 | Aldose reductase-IN-5 | ||
Aldose reductase-IN-5 is an inhibitor of aldose reductase (ALR2) that enhances the combination of inhibitory excitability and antioxidant capacity, thereby delaying the diabetes complications progress. | |||
T61957 | Aldose reductase-IN-3 | ||
Aldose reductase-IN-3 (Compound 5) is an effective and moderately selective aldose reductase (AR) inhibitor (IC50=3.99 μ M). Aldose reductase is a molecular target involved in various inflammatory diseases (including sep... | |||
T60601 | Aldose reductase-IN-4 | ||
Aldose reductase-IN-4 (compund IIc) is an inhibitor of aldose reductase with IC50s of 11.70 μM and 0.98 μM for ALR1 and ALR2, respectively [1]. | |||
T5195 | Alrestatin | AY-22284 | Reductase |
Alrestatin (AY-22284) is a specific inhibitor of aldose reductase and attenuates glucose-induced angiotensin II production in rat vascular smooth muscle in vitro. | |||
T1458 | Epalrestat | ONO2235 | Reductase |
Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particul... | |||
T0725 | Isoliquiritigenin | ISL,Isoliquiritigen,GU17 | Apoptosis , Influenza Virus , Reductase , Autophagy |
Isoliquiritigenin (ISL), an anti-tumor flavonoid from the root of Glycyrrhiza glabra, suppresses aldose reductase (IC50=320 nM). | |||
T15568 | Imirestat | Alcon 1576,AL 1576,HOE 843 | Reductase |
Imirestat (HOE 843) is an aldose reductase inhibitor that can be used in diabetes research. | |||
T3801 | (Rac)-Byakangelicin | Bjacangelicin,Bjakangelicin,Biacangelicin,7H-Furo[3,2-g][1]benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-,Byakangelicin | Others |
(Rac)-Byakangelicin (7H-Furo[3,2-g][1]benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-) is an antineoplastic agent. |